This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Daniel F. Hartman, MD; Richard L. Goode, MD

Arch Otolaryngol Head Neck Surg. 1987;113(7):720-723.

Abstract
• The use of composite grafts in facial reconstruction has been limited by a history of unpredictable survival beyond a radius of 1 cm. Numerous pharmacologic agents have been employed to improve the survival of random skin flaps but, to our knowledge, have not been studied in composite grafts. Three agents that have demonstrated efficacy in random skin flap survival, intravenous heparin sodium, topical nitroglycerin, and intramuscular methylprednisolone sodium succinate, were investigated for their effect on composite graft survival. Using a rabbit model, full-thickness auricular composite grafts were created, rotated 180°, and reattached. At 21 days, all grafts were assessed for area of survival and postexcisional weight. Animals receiving 30 mg/kg of intramuscular methylprednisolone sodium succinate daily, during the first four postoperative days, demonstrated a significant increase in graft survival compared with controls. Heparin and nitroglycerin produced no change compared with controls. Furthermore, the only grafts to achieve 100% survival were found in the group treated with methylprednisolone.

(Arch Otolaryngol Head Neck Surg 1987;113:720-723)

Author Affiliations
From the Division of Otolaryngology/Head and Neck Surgery, Stanford (Calif) University, and the Palo Alto (Calif) Veterans Administration Medical Center.

Footnotes
Accepted for publication April 14, 1987.

Read at the fall meeting of the American Academy of Facial Plastic and Reconstructive Surgery, San Antonio, Tex, Sept 13, 1986.

Reprint requests to Division of Otolaryngology/Head and Neck Surgery, R-135, Stanford University Medical Center, Stanford, CA 94305 (Dr Goode).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Use of hyperbaric oxygen to enhance auricular composite graft survival in the rabbit model.
Lewis et al.
Arch Facial Plast Surg 2006;8:310-313.
ABSTRACT | FULL TEXT  

Enhancement of Auricular Composite Graft Survival With Hyperbaric Oxygen Therapy
Renner et al.
Arch Facial Plast Surg 2002;4:102-104.
ABSTRACT | FULL TEXT  

Composite Graft Survival: An Auricular Amputation Model
Henrich et al.
Arch Otolaryngol Head Neck Surg 1995;121:1137-1142.
ABSTRACT  

Pharmacologic and Surgical Enhancement of Composite Graft Survival
Fann et al.
Arch Otolaryngol Head Neck Surg 1993;119:313-319.
ABSTRACT